Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Decitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 186 Myelodysplastic Syndromes 82 Leukemia 39 Leukemia, Myelomonocytic, Chronic 36 Recurrence 24 Myeloproliferative Disorders 15 Congenital Abnormalities 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Lymphoma, Large B-Cell, Diffuse 13 Neoplasms 11 Primary Myelofibrosis 9 Melanoma 9 Blast Crisis 9 Thrombocythemia, Essential 7 Polycythemia Vera 7 Leukemia, Myelomonocytic, Acute 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Monocytic, Acute 7 Hodgkin Disease 7 Carcinoma, Non-Small-Cell Lung 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Ovarian Neoplasms 6 Myelodysplastic-Myeloproliferative Diseases 6 Anemia, Refractory, with Excess of Blasts 6 Neoplasm Metastasis 5 Lymphoma 5 Leukemia, Myeloid, Accelerated Phase 5 Leukemia, Biphenotypic, Acute 5 Lymphoma, Non-Hodgkin 4 Lung Neoplasms 4

Interventions

Rituximab 111 Cyclophosphamide 100 fludarabine 59 Doxorubicin 32 Etoposide 31 Vincristine 30 Prednisone 30 Lenalidomide 24 ibrutinib 22 fludarabine phosphate 21 obinutuzumab 18 Immunotherapy, Adoptive 18 Cytarabine 18 Bendamustine Hydrochloride 18 pembrolizumab 16 Magnetic Resonance Spectroscopy 15 Bortezomib 14 polatuzumab vedotin 12 Specimen Handling 12 Dexamethasone 12 CT-P10 12 venetoclax 11 Gemcitabine 11 Carboplatin 11 pirtobrutinib 10 glofitamab 10 zanubrutinib 9 Nivolumab 9 Mycophenolic Acid 9 Melphalan 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01799083 2016-01-28

CIK

Chinese PLA General Hospital

Phase 1/2 Unknown

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡